Photo: George Frey/Getty Images

The Food and Drug Administration has approved a record number of generic drugs, but at the same time it’s inspecting a lot fewer of the factories where those drugs are made.

Why it matters: Declining inspections are raising new concerns about their quality and safety, Bloomberg’s Anna Edney reports in the first part of a yearlong investigation.

  • And in addition to a drop in overall inspections, the FDA has in some cases been slow to crack down on the problems it does find, Edney reports.

By the numbers: Generics make up roughly 90% of all U.S. prescriptions.

  • FDA inspections of facilities inside the U.S. fell by 11% from 2017 to 2018 and have been falling since 2011, when the agency began shifting more resources overseas.
  • But international inspections, after rising steadily for years, have also been on the decline since 2016.
  • Companies from India and China alone account for almost half of all new generic drugs, and more than 80% of drugs' active ingredients are made abroad.

Between the lines: The story also includes 2 anecdotes in which FDA inspectors uncovered violations and began work on enforcement letters, but "higher-ups at the FDA … overrode the concerns of those on the ground."

The other side: "It’s not the number of inspections we do, it's whether we're targeting effectively," FDA Commissioner Scott Gottlieb told Bloomberg.

  • Janet Woodcock, who leads the agency’s center for drug reviews, also said the agency’s oversight is "better than it's ever been."

Go deeper: Why the spotlight on generic drug prices is getting brighter

Go deeper

McEnany spars with reporters over whether Trump condemned white supremacy

White House press secretary Kayleigh McEnany clashed repeatedly with members of the media on Thursday over whether or not President Trump has forcefully condemned white supremacy, at one pointing accusing CNN's Kaitlan Collins of asking a "partisan attack question."

Why it matters: It was one of the most confrontational press conferences yet by a White House press secretary brought in for the express purpose of sparring with a Washington press corps that the president has attacked as "the enemy of the people."

Updated 2 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Eniola Odetunde/Axios

  1. Global: Total confirmed cases as of 11 a.m. ET: 34,026,003 — Total deaths: 1,015,107 — Total recoveries: 23,680,268Map.
  2. U.S.: Total confirmed cases as of 11 a.m. ET: 7,237,043 — Total deaths: 207,008 — Total recoveries: 2,840,688 — Total tests: 103,939,667Map.
  3. Health: New poll shows alarming coronavirus vaccine skepticism — New research centers will study "long-haul" COVID — Coronavirus infections rise in 25 states.
  4. Business: Remdesivir is good business for Gilead.
  5. Transportation: The politics of pandemic driving.
  6. 🎧Podcast: The looming second wave of airline layoffs.
2 hours ago - Technology

Senate panel votes to subpoena Big Tech CEOs

Photo: Graeme Jennings/Pool via Getty Images

The Senate Commerce Committee has voted to authorize subpoenas compelling Facebook CEO Mark Zuckerberg, Twitter CEO Jack Dorsey and Google CEO Sundar Pichai to testify before the panel.

Why it matters: The tech giants are yet again facing a potential grilling on Capitol Hill sometime before the end of the year, at a time when tech is being used as a punching bag from both the left and right.